|
|
40
|
|
|
A681BN
|
|
|
KIVEXA 600MG | 300MG TAB (GSK/COL) ABACAVIR | LAMIVUDINE
|
|
|
ABACAVIR|LAMIVUDINE
|
|
|
KIVEXA
|
|
|
30'S
|
|
|
BL
|
|
|
162.04
|
|
|
5.40
|
|
|
600MG|300MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
GSK
|
|
|
GLAXOSMITHKLINE
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
08180892
|
|
|
ANTIRETROVIRALS MISCELLANEOUS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|